| Serial Number | 87756187 |
| Word Mark | BRAFTOVI ENCORAFENIB CAPSULES |
| Filing Date | Tuesday, January 16, 2018 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Saturday, July 13, 2024 |
| Registration Number | 5625743 |
| Registration Date | Tuesday, December 11, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 25, 2018 |
| Description of Mark | The mark consists of three sphere designs diagonally above the word "BRAFTOVI" over the words encorafenib capsules, wherein the term encorafenib is in parentheses. |
| Amendment to a Registration/Renewal Certificate | In the statement, Column 2, lines 4-22, " Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; for the prevention and and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma " is deleted. |
| Goods and Services | [ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use;] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma ] |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "CAPSULES" AND "ENCORAFENIB" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 28, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, July 2, 2018 |
| First Use In Commerce Date | Monday, July 2, 2018 |
| Party Name | Array Biopharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Party Name | Array Biopharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Party Name | Array Biopharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Event Date | Event Description |
| Thursday, April 26, 2018 | ASSIGNED TO EXAMINER |
| Friday, January 19, 2018 | NEW APPLICATION ENTERED |
| Sunday, January 28, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 30, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 3, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, May 3, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, May 3, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 10, 2018 | TEAS AMENDMENT OF USE RECEIVED |
| Wednesday, July 11, 2018 | USE AMENDMENT FILED |
| Wednesday, July 11, 2018 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, July 12, 2018 | USE AMENDMENT ACCEPTED |
| Friday, July 13, 2018 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Thursday, August 9, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 9, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 9, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 9, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 9, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 21, 2018 | ASSIGNED TO LIE |
| Wednesday, September 5, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 25, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 25, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 11, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, June 4, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, June 4, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, June 4, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 4, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 4, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, July 16, 2020 | TEAS SECTION 7 REQUEST RECEIVED |
| Monday, November 16, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, November 16, 2020 | AMENDMENT UNDER SECTION 7 - PROCESSED |
| Monday, December 11, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, January 2, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Saturday, July 13, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Saturday, July 13, 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Saturday, July 13, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |